We have exciting news to share! After serving the pharma and biotech verticals for the past decade, we are leveraging our expansion of talent and services to create our newest practice area – FDA and Healthcare Regulatory. Ben Martie, who joined Morningstar Law Group in 2022 with over ten years of experience in the pharma industry, including as in-house counsel and compliance officer, shares our excitement, “Over the last year, the firm has significantly expanded its capabilities and support for FDA-regulated businesses, such as pharmaceutical, biotech, and medical device companies and CDMOs. Today, I am delighted to announce the formal launch of the FDA and Healthcare Regulatory practice group at Morningstar. With this addition, the firm further demonstrates its tireless commitment to FDA-regulated businesses and the patients they serve. As the firm’s work continues, I know its efforts in this space will also, and I am excited for the road ahead.”
To learn more about the FDA and Healthcare Regulatory team and services offered, visit the practice area’s home on our website HERE.
